Heparin – ACT Dynamics: Before and After “New” Heparin (Video)
Jeff Riley discusses observations from the Mayo Clinic regarding the new Heparin that is now on the market (17 minutes).
World's Largest Resource for Cardiovascular Perfusion
Jeff Riley discusses observations from the Mayo Clinic regarding the new Heparin that is now on the market (17 minutes).
Bivalirudin infusion in children should be started after loading dose at rates greater than those used in adults. Dose in neonates remains uncertain because neither pharmacokinetics nor coagulation pharmacodynamics have been adequately characterized.
This work aims to evaluate the regenerative potential of platelet-rich plasma (PRP) on an implant site of peculiar clinical impact, such as sinus augmentation.